Becton Dickinson (BDX) Cash from Investing Activities (2009 - 2026)
Becton Dickinson (BDX) reported Cash from Investing Activities of -$139.0 million for Q1 2026, down 4.51% year-over-year from -$145.6 million in Q1 2025, and up 24.04% quarter-over-quarter from -$183.0 million in Q4 2025.
Becton Dickinson (BDX) Cash from Investing Activities (2009 - 2026) Analysis & Trends
Becton Dickinson (BDX) has 18 years of Cash from Investing Activities data on file, last reported at -$139.0 million in Q1 2026.
- Cash from Investing Activities for Q1 2026 came in at -$139.0 million, down 4.51% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.2 billion (up 70.85% YoY), and the FY2025 annual result was -$818.0 million, up 85.17% from the prior year.
- Cash from Investing Activities advanced to -$139.0 million in Q1 2026 per BDX's latest filing, from -$183.0 million in the prior quarter.
- Over five years, Cash from Investing Activities peaked at $204.0 million in Q4 2024 and troughed at -$3.9 billion in Q3 2024.
- A 5-year average of -$582.8 million and a median of -$288.0 million in 2024 frame the typical range for Cash from Investing Activities.
- On a YoY basis, Cash from Investing Activities climbed as much as 187.55% in 2024 and fell as far as 2973.72% in 2024.
- A 5-year view of Cash from Investing Activities shows it stood at -$291.0 million in 2022, then grew by 19.93% to -$233.0 million in 2023, then soared by 187.55% to $204.0 million in 2024, then slumped by 189.71% to -$183.0 million in 2025, then climbed by 24.04% to -$139.0 million in 2026.
- Business Quant data shows BDX's Cash from Investing Activities at -$139.0 million in Q1 2026, -$183.0 million in Q4 2025, and -$494.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | -914.50 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -139.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | -96.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | -58.03 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | -42.70 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | -77.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -90.00 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | -131.58 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -133.00 Mn |
| 10 | Aptargroup | 7.72 Bn | 7.52 Bn | 351.91 Mn | -65.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -139.00 Mn |
| Mar 31, 2026 | -139.00 Mn |
| Dec 31, 2025 | -183.00 Mn |
| Dec 31, 2025 | -183.00 Mn |
| Sep 30, 2025 | -494.00 Mn |
| Sep 30, 2025 | -494.00 Mn |
| Jun 30, 2025 | -395.00 Mn |
| Jun 30, 2025 | -395.00 Mn |
| Mar 31, 2025 | -133.00 Mn |
| Mar 31, 2025 | -133.00 Mn |
| Dec 31, 2024 | 204.00 Mn |
| Dec 31, 2024 | 204.00 Mn |
| Sep 30, 2024 | -3.94 Bn |
| Sep 30, 2024 | -3.94 Bn |
| Jun 30, 2024 | -288.00 Mn |
| Jun 30, 2024 | -288.00 Mn |
| Mar 31, 2024 | -1.06 Bn |
| Mar 31, 2024 | -1.06 Bn |
| Dec 31, 2023 | -233.00 Mn |
| Dec 31, 2023 | -233.00 Mn |